Evaluation of Brentuximab Vedotin for Diffuse Cutaneous Systemic Sclerosis: A Phase I/II Multicenter, Randomized, Double-Blinded Safety Study - Fixed Price Code
Clinical Trial Grant
Administered By
Medicine, Rheumatology and Immunology
Awarded By
Benaroya Research Institute at Virginia Mason
Start Date
February 1, 2018
End Date
January 31, 2023
Administered By
Medicine, Rheumatology and Immunology
Awarded By
Benaroya Research Institute at Virginia Mason
Start Date
February 1, 2018
End Date
January 31, 2023